Candriam Equities L Biotech.R EUR Acc H/  LU1708110975  /

Fonds
NAV7/1/2020 Chg.+1.1700 Type of yield Investment Focus Investment company
192.6200EUR +0.61% reinvestment Equity Worldwide Candriam Luxembourg 

Monthly performance

  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total
2017 - - - - - - - - - - - 1.34 -
2018 6.48 -4.79 -2.32 -3.39 4.34 0.61 4.25 3.89 -2.24 -14.23 3.82 -8.57 -13.41%
2019 12.85 3.39 -0.87 -5.17 -4.67 9.21 -2.39 -2.50 -4.71 10.98 11.86 2.55 +31.84%
2020 -5.41 -1.57 -5.43 12.20 9.47 1.26 0.61 - - - - - -

Calculated values

  YTD 6 Months 1 Year 3 Years 5 Years
Volatility 38.20% 38.34% 29.48% -% -%
Sharpe ratio 0.57 0.60 0.90 - -
Best month +12.20% +12.20% +12.20% +12.85% -
Worst month -5.43% -5.43% -5.43% -14.23% -
Maximum loss -25.36% -25.36% -25.40% - -
Outperformance -4.93% - +2.40% - -
 
All quotes in EUR

Tranches

Name   Type of yield Repurchase p. 1 Year 3 Years
Candriam Equities L Biotech.V US... reinvestment 1,801.4700 +29.01% +40.92%
Candriam Equities L Biotech.I EU... reinvestment 1,966.4900 +26.01% +30.31%
Candriam Equities L Biotech.R US... reinvestment 230.7100 +29.50% +41.64%
Candriam Equities L Biotech.R EU... reinvestment 192.6200 +26.18% -
Candriam Equities L Biotech.I US... reinvestment 4,949.6299 +28.85% +40.42%
Candriam Equities L Biotech.C EU... reinvestment 190.5700 +25.27% +27.03%
Candriam Equities L Biotech.C US... reinvestment 749.7300 +28.49% +38.38%
Candriam Equities L Biotech.C US... paying dividend 701.9800 +28.44% +38.25%

Performance

YTD  
+10.18%
6 Months  
+10.56%
1 Year  
+26.18%
3 Years     -
5 Years     -
Since start  
+29.22%
Year
2019  
+31.84%
2018
  -13.41%